GEN-MKT-18-7897-A
Aug 17, 2015 | Blogs, Food / Beverage | 0 comments
If you suffer from peanut allergies, you may want to think twice before diving into a bowl of something spicy. The reason being, some shipments of North American and European products containing ground cumin, cumin powder, cayenne pepper, paprika, and pilli-pilli powder have been found to contain undeclared peanut and almond proteins. Think dinner kits, supermarket curries, veggie and black bean burgers, and salsa.
Here is how it all started: In 2014, the Canadian Food Inspection Agency (CFIA) discovered undeclared peanut and almond protein in products containing cumin. Then, in December 2014, North American cumin samples turned up containing peanut protein. In February 2015, the FDA issued a statement declaring that people with highly sensitive peanut allergies should avoid these foods. Products containing known contaminants were then recalled in rapid succession. In all, 20 alerts were issued by the FDA and products were recalled throughout Europe. Some experts say the trace amounts of protein are the results of poor harvest and crop failure, with nuts used as a substitute. The American Spice Trade Association (ASTA) has taken a more conservative approach pointing out that spices such as cumin are grown alongside peanuts resulting in low-level cross-contact.
You can be certain labs are receiving an influx of spices for which to test. However, can we trust the results? To date, testing has not been fool-proof. Traditionally enzyme-linked immunosorbent assay (ELISA)-based methods are used for food allergen testing. However, ELISA is plagued by false positive and false negative outcomes.
What is the Solution?
Here at SCIEX, we propose a multi-allergen screening method to do the job. This LC-MS/MS application delivers:
Together, we can help keep allergens out of spices for good. To read the full application note click here.
It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Here is an overview of just some of the ways SCIEX is working to support these challenges.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
Posted by
You must be logged in to post a comment.
Share this post with your network